مواقع التدريسيينجامعة الكوفة
0Publications
0Lectures
0Interests
0News

About

Name: Ammar Jubbar Majeed Alkhalidi
Date of birth: 22/9/1980
Address : Al-Najaf/ Iraq

Graduated from college of medicine/ Kufa university at 2006 as MBChB

Complete 2 years of residency in Al Sader teaching hospital

Graduated as fellow of Iraqi Board for Medical Specialization in internal medicine on November,2014.

Assessted professor in kufauniversity,college of medicine

Now studying deploma in interventional cardiology in Al Najaf cardiac center.

Subspeciality cardiology at 2019

Research Interests

2

Publications

7
2020

Complications of Trans-catheter Aortic Valve Implantation in Al-Najaf Cardiac Center

AuthorsAmmar Jabbar Mejeed, Khalid I.Amber
JournalInternational Medical Journal
Abstract

ABSTRACT— The present paper aims to evaluate immediate and short term complications of trans-catheter aortic valve implantation for four years’ period in Al-Najaf Cardiac Center, Iraq. A 53 patients with symptomatic severe aortic stenosis, mean age of (72.9 ± 5.6) years and (54.72%) males, they had high Society of Thoracic Surgeon (STS) score, Underwent trans-catheter aortic valve implantation procedure in Al-Najaf Cardiac Center from January 2015 to August 2019. The procedure was done under local anesthesia and conscious sedation via femoral approach, using both balloon expandable and self-expandable valves. All patients followed immediately post procedure and during period of hospitalization and thereafter periodically for procedure and valve related complications. Immediate and short term mortality was 5.66%, with majority occurs immediately after procedure due to severe paravalvular leak, rupture annulus and cholesterol embolization. Major vascular complications, moderate-severe paravalvular leak and conduction abnormalities were 5.88%, 15.45% and 37.73% respectively. Permanent pacemaker need for only two patients. We observed increase risk of pericardial effusion with balloon expandable valve (p value=0.019). Occurrence of other complications not significantly differs regarding type of valve. This study showed favorable rate of survival with procedural complication rates similar to international registered results. KEYWORDS: Trans-catheter, Aortic Valve Implantation

2020

Influence of High resolution computed tomography (HRCT) in reviewing the diagnosis of chronic obstructive pulmonary disease (COPD) , a study of 16 male patients

AuthorsDr Ammar Jabbar Majeed FICMS,DM,MBChB. [email protected], Dr FalahAbdulhasan Deli FICMS, DM, MBChB [email protected] Dr Samet Elias Kasim FICMS, MBChB [email protected] Dr Asaad Shukur DM
JournalAnnals of Tropical Medicine and Public Health
Abstract

Abstract Background Chronic obstructive pulmonary disease (COPD) is manifested mainly as two main clinical phenotypes chronic bronchitis and emphysema. It is characterized by the presence of poorly reversible airflow obstruction, the presence of other histopathological changes may contribute to the poor response to treatment in many patients Aim of study To detect additional changes that involve the lung tissue such as interstitial lung fibrosis in COPD patient. Patients and Methods This cross-sectional study was carried out on (16) male patients diagnosed with COPD. All patients wereduring the stable state, and investigated by spirometry and HRCT. Results Eight patients had emphysema, four had emphysema and lung fibrosis, two had traction bronchiectasis, one with apical fibrosis and another with possible lung neoplasm, four patients (out of seven) who had obstructive and restrictive pattern on spirometry had interstitial changes compared to two (out of nine of those with obstructive pattern only Conclusions and Recommendations HRCT scan is an important diagnostic tool to detect other pulmonary changes that can occur in patients with COPD. Larger studies are needed and obtaining histopathological assessment for these patients.

2015

Correlation Between Helicobacter Pylori Infection and Severity of Asthma

AuthorsSabah Ali Jaber Alhelu, Abdul-Razzaq Hassan Alkaaby, specialist of medicine/Alsader medical city, Najaf/ M.B.Ch.B ,DM,CABM Ammar Jabbar Majeed , department of medicine /Kufa university/ M.B.Ch.B, FICM Sadiq J. Ali Almuhana ,professor of medicine /Kufa university/M.B.Ch.B ,DM,CABM
JournalKUFA JOURNAL FOR NURSING SCIENCES
Abstract

الخلاصة خلفیة الدراسة: طالما كان یعتقد إن الإصابات الجرثومیة توفر حمایة من إمراض الحساسیة،وقلة التعرض للجراثیم المعویة أعطت تفسیر لزیادة انتشار الربو وزیادة شدتھ،ولذلك بما إن الانتشار العام للإصابة بالملویات البوابیة بدأ بالانحسار، لذلك وجدنا أن نتیجة الفحص المناعي للإصابة بالملویات البوابیة تتناسب عكسیا مع شدة الإصابة بالربو المزمن. الھدف :الھدف من ھذه الدراسة ھو تحدید ھل أن الإصابة السابقة بالملویات البوابیة تقلل من احتمالیة حدوث حالة الربو الشدید عند مرضى الربو المزمن. المنھجیة : شارك في ھذه الدراسة خمسون مریض مصابون بالربو المزمن ، یتكونون من ١٩ ذكر و ٣١ أنثى تتراوح أعمارھم بین ١٧ و ٦٦ سنة ، من كل ھؤلاء المرضى تم اخذ تاریخ مرضي شامل وخضعوا لفحص سریري كامل، بعد ذلك اجري لھم فحص وظائف الرئة ، من ثم سحب من كل مریض عینة بمقدار ٢ ملیلیتر من الدم الوریدي،من ثم تم إجراء الطرد المركزي للعینة وأرسلت لغرض إجراء فحص الملویات البوابیة المناعي. النتائج: تم إیجاد علاقة إحصائیة معتبرة بین شدة الربو والنتائج الموجبة لفحص الملویات البوابیة المناعي ،حیث كلما زادت شدة الربو كلما قلت نسبة النتائج الموجبة للفحص المناعي،كذلك تم إثبات عدم وجود علاقة إحصائیة معتبرة تربط أعمار المرضى أو أجناسھم بنتائج الفحص المناعي. الاستنتاج : ھناك علاقة عكسیة بین شدة الربو القصبي ونتائج فحص الملویات البوابیة المناعي. التوصیات: نظرا لعدم وضوح العلاقة المباشرة بین الملویات البوابیة والربو القصبي نوصي بالمزید من الدراسات لاكتشاف تلك العلاقة . ABSTRACT Background: Microbial exposures have been suggested to confer protection from allergic disorders, and reduced exposures to gastrointestinal microbes have been proposed as an explanation for the increase in asthma severity and prevalence. Since the general prevalence of Helicobacter pylori has been decreasing, we hypothesized that H. pylori serostatus may be inversely related to the severity of asthma. Objective: The aim of this study is to find whether infection with H.pylori reduces the probability of development of severe asthma in patients with persistent asthma. Patients and methods: In this study fifty patients with persistent asthma includes 19 males and 31 females their ages range from (17 – 66) years For all those patients, full history and complete physical examination have been done, then after, the patients subjected to pulmonary function test. After that, two milliliters sample of venous blood have been drawn, then, the sample centrifuged and sent to assess for H.pylori infection serology. Data was analyzed by using SPSS. Results: There is significant association between severity of asthma and result of H.pylori so with increase severity of asthma there is decrease in percentage of positive H.pylori serology. And there is no statistical significant are noted between patients sex or age and results of H.pylori infection test. Conclusion: There is significant inverse association between severity of asthma and result of H.pylori infection serology. This association not affected by ages and sex of patients. Recommendations: Since the exact mechanism by which H.pylori affect asthma is not clear, there is need for further studies to explore it. Keywords: Helicobacterpylori, serology test, pulmonary function test, asthma.

2025

DMF)andHeparinSulfateMitigateCerebralIschemia-ReperfusionInjury in MaleRats

AuthorsKarrar aljabri, Ammar Jabbar Majeed
JournalJournalofNeonatalSurgery|Year:2025|
Date2025-03-02
Abstract

1275-1283.ABSTRACTIschemic cerebrovascular illness leads in oxygen deprivation to brain tissue, which can generate reactive oxygen species(ROS) and immune cell mediators are released after reperfusion, which can happen naturally through thrombus breakdown or through therapeutic recanalization. After a week of acclimatization, the rats were split into five groups as follows: Shamgroup: The animals got general anesthesia without having their unilateral carotid artery occluded. The animals in the ischemic-reperfused control group got general anesthesia, a 5-minute occlusion of the carotid artery, and an hour-long reperfusionwithouttheadministrationofmedication.Vehiclegroup:Theanimalsunderwentthesamesurgeryasthecontrol group,buttheyalsoreceivedintraperitoneal(i.p.)doseofDSMO5min.followingtheischemia.Grouptreatedwithheparin sulfate: 5 min. after the ischemia, theanimals underwent the same surgical approach as the control group, but they additionallyreceived400IU/kg(i.p.).Grouptreatedwithdimethylfumarate:5min.aftertheischemia,theanimalsreceived thesamesurgicalapproachasthecontrolgroup,plustheyweregiven50mg/kgofdimethylfumarateintraperitoneally(i.p.). ROS levelsandbraintissuedamageweresignificantlydecreased (P<0.05)inthetreatedgroups.Histologically,thetreated animalshadlessbraintissuedamagethanthecontrolandvehiclegroups(P<0.05).Comparedtotheheparinsulfategroup, the DMF group displayed a higher reduction in ROD and brain damage. Conclusion, DMF has a neuroproctive impact on cerebralI/Rinjurybydownregulatingoxidativestressandloweringthepercentageofinfarctionarea,whileheparinalsohas this effec

2024

Early Outcomes of Transcatheter Aortic Valve Implantation with Early Outcomes of Transcatheter Aortic Valve Implantation with Next-Generation Balloon-Expandable Myval Transcatheter Heart Next-Generation Balloon-Expandable Myval Transcatheter Heart Valve: Single-Center Experience from Iraq Valve: Single-Center Experience from Iraq

AuthorsKhalid amber, Ammar Jabbar Majeed
JournalJournal of the Saudi Heart Association
Date2024-05-17
Abstract

Abstract Objectives: Transcatheter aortic valve implantation (TAVI) is a minimally invasive percutaneous procedure for the treatment of elderly patients with symptomatic severe aortic stenosis. The study aimed to determine immediate (in-hospital) and short-term (30-day) outcomes of TAVI with next-generation balloon-expandable Myval transcatheter heart valve (THV) at a single-centre in Iraq. Methods: During January 2019 to January 2024, a total of 100 symptomatic severe aortic stenosis patients who underwent TAVI using Myval THV at Al-Najaf Cardiac Center, Iraq were enrolled. The procedure was done under local anesthesia and conscious sedation via transfemoral approach, using balloon-expandable Myval THV. All patients were followed-up at post-procedure, during hospitalization and thereafter periodically for procedural and clinical outcomes and complications. Results: The mean age of these patients was 73.8 ± 6.5 years and there were equal proportion of male and female patients. Immediate post-procedure and short-term mortality was 1%, while vascular complications, moderate paravalvular leak and overall conduction abnormalities were 11%, 4% and 21%, respectively at 30-day follow-up. Only six patients (6%) required a new permanent pacemaker. Post-procedural mean pressure gradient was 5.44 ± 2.38 mmHg. None of the treated patients experienced coronary artery occlusion. Cerebrovascular complication (transient and non-disabling) was noted in one patient. Conclusion: In patients with native symptomatic severe aortic stenosis, TAVI using novel, next-generation, ballon-expandable Myval THV offers a safe and reliable treatment option with good procedural success and survival rates and fewer complications.

2025

Early Conduction Abnormalities Following Trans Catheter Aortic Valve Implantation In Al Najaf Cardiac Center: Single-Center Experience From Iraq.

AuthorsAmmar Jabbar Majeed
JournalAfrican Journal of biomedical Research
Date2025-01-09
Abstract

Abstract Objectives: Trans catheter aortic valve implantation (TAVI) is an increasingly utilized minimally invasive procedure designed for elderly patients experiencing symptomatic severe aortic stenosis, particularly those identified as intermediate or high-risk for traditional surgical intervention. This study focused on evaluating both immediate (in-hospital) and short-term (30-day) conduction abnormalities post-TAVI at a single center in Iraq. Methods: From January 2017 to March 2024, a cohort of 213 symptomatic patients with severe aortic stenosis underwent TAVI, employing both balloon-expandable and self-expanding trans catheter heart valves (THVs) at the Al Najaf Cardiac Center. All procedures were conducted under local anesthesia with conscious sedation via a trans femoral access. Patients were monitored for electrical conduction abnormalities during hospitalization and through periodic follow-ups. Results: The study examined the prevalence of conduction abnormalities in 213 TAVI patients, with a mean age of 73.58 years (±6.35) and a male representation of 48.8%. The Myval valve was predominantly used (121 patients), followed by Evolute R (83 patients), and the Accurate Neo 2 valve (9 patients). Among the participants, 72.9% exhibited no conduction abnormalities, whereas 16.8% developed left bundle branch block (LBBB), 1.4% experienced first-degree heart block, and 8.4% had complete heart block (CHB). Notably, LBBB was more prevalent among female patients (21 cases) compared to male patients (15 cases); however, this gender difference was not statistically significant, indicating that gender alone is not a reliable predictor of LBBB occurrence after the procedure. A statistically significant correlation was found between pre-dilation and the incidence of LBBB (p = 0.045), suggesting that pre-dilation may reduce LBBB risk. In contrast, post-dilation did not significantly affect LBBB rates (p = 0.791). The type of valve used was a significant factor associated with LBBB development (p = 0.02), with Myval valves showing a higher incidence than both Evolute and Accurate Neo 2 valves. However, valve type did not significantly influence CHB rates (p = 0.831), indicating that factors leading to CHB may not be as related to valve type. Furthermore, valve size did not demonstrate a significant association with LBBB (p = 0.13) or CHB (p = 0.861). Conclusion: TAVI, utilizing both self-expanding and balloon-expandable THVs, is a safe and effective alternative to surgical intervention for patients with symptomatic severe aortic stenosis. Nevertheless, the procedure carries a risk of significant complications, such as conduction abnormalities, particularly LBBB, which is more frequently observed with balloon-expandable valves and among female patients. CHB represents a second frequent conduction abnormality with no significant correlation to valve type or size.

2025

Non-graft stent for the treatment of women with aorta coarctation

AuthorsYassen abdulreda , Ammar Jabbar Majeed
JournalInternational Journal of Medical Toxicology & Legal Medicine
Date2025-01-23
Abstract

ABSTRACT Aortic Coarctation is one of the common congenital heart diseases.It is ranks sixth in frequency of congenital heart disease. It is a narrowing of aorta mostly in the region of the ligamentum arteriosum.Correction of coarctation of aorta is indicated in patient with symptom related to stenosis and hypertension related to coarctation, also when pressure gradient more than 20 mmHg and significant difference of blood pressure between upper limb and lower limb more than 20 mmHg.The operation was effective in all women without any immediate serious problems. Follow-up results indicated sustained improvement in pressure gradients and considerable therapeutic effects. Modest complications included local hematoma at the access site in 3 women, which resolved with conservative care. There are no occurrences of stent migration, aneurysm development, or re-stenosis were detected during the follow-up period. These data demonstrate that stent implantation for aortic coarctation is a safe and effective treatment option, producing persistent hemodynamic and clinical benefits.After one month following the procedure, there was no significant increase in blood pressure. Most patients achieved controlled blood pressure, with 22 women maintaining control without medication, 14 women requiring a single antihypertensive medication, and the remaining 4 women needing two or more antihypertensive drugs.

Lectures

3

News & Announcements

2
News 2025-02-16

Participate in ESC Barcelona

This conference deal with last update in treatment of cardiac disease and interventions

News 2025-02-16

Participate in EUROPCI IN Paris

This conference deal with last update in cardiovascular trans catheter intervention

View details